Kaleido Biosciences, Inc.
KLDO
$0.002
$0.00191,900.00%
OTC PK
12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -30.87% | -22.68% | -22.07% | 99.82% | -15.24% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 0.08% | 0.88% | -1.72% | 6.84% | -58.35% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -27.43% | -21.85% | -21.50% | 95.05% | -21.96% |
|
|||||
Total Current Assets | -27.43% | -21.85% | -21.50% | 95.05% | -21.96% |
Net Property, Plant & Equipment | -22.81% | -2.48% | -3.92% | -7.43% | -1.05% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Assets | -26.06% | -19.56% | -19.74% | 76.98% | -18.87% |
|
|||||
Total Accounts Payable | 59.31% | 32.06% | 11.73% | -55.24% | 40.52% |
Total Accrued Expenses | -22.98% | 73.14% | 13.88% | -40.14% | -9.16% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 152.88% | 74.09% | -22.95% | 80.68% | 108.55% |
Total Finance Division Other Current Liabilities | 85.56% | -28.67% | -31.25% | 1.48% | 59.60% |
Total Other Current Liabilities | 85.56% | -28.67% | -31.25% | 1.48% | 59.60% |
Total Current Liabilities | 54.10% | 56.99% | -4.69% | -22.73% | 19.01% |
|
|||||
Total Current Liabilities | 54.10% | 56.99% | -4.69% | -22.73% | 19.01% |
Long-Term Debt | -63.32% | -14.40% | 7.57% | -10.57% | -6.08% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 2.07% | 3.26% | 3.35% | 3.46% | 3.61% |
Total Liabilities | 2.40% | 13.46% | 2.32% | -14.40% | 4.31% |
|
|||||
Common Stock & APIC | 0.45% | 0.54% | 0.65% | 25.22% | 1.59% |
Retained Earnings | -5.89% | -7.19% | -8.04% | -8.40% | -7.88% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -63.67% | -41.91% | -29.97% | 250.19% | -42.91% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -63.67% | -41.91% | -29.97% | 250.19% | -42.91% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -63.67% | -41.91% | -29.97% | 250.19% | -42.91% |
|